TSX closed
Loading markets…
Stocks/NASDAQ/MEDP

Medpace Holdings Inc (MEDP : NASDAQ)

Common Stock

$677.56

USD

-15.12 (-2.18%)

Last updated: 2026-10-29

Follow MEDP

MEDP

Medpace Holdings Inc

Source:WealthAwesomeWealthAwesome
↑ $65.23 (10.65%)
30 day period
$598.08$645.38$692.68Sep 18Oct 9Oct 29

Performance

1 Day

-2.18%

1 Week

+3.61%

1 Month

+8.91%

YTD

+18.66%

Key Statistics

Market Cap

$19.38B

52W High

$693.97

52W Low

$373.00

P/E Ratio

38.46

50 Day MA

$616.95

200 Day MA

$528.85

Beta

1.18

Dividend Yield

-

Technical Indicators

Price vs 50-Day SMA

↑Above 50 SMA

Price vs 200-Day SMA

↑Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
10/29/2026$690.00$690.00$676.22$677.56$677.56250,314
10/28/2026$671.56$693.97$671.56$692.68$692.68301,522
10/27/2026$670.67$680.77$669.76$673.79$673.79195,595
10/26/2026$671.46$678.41$663.61$676.77$676.77306,534
10/23/2026$654.98$670.18$645.93$669.20$669.20309,400
10/22/2026$657.11$684.52$645.29$653.96$653.96893,947
10/21/2026$614.98$666.65$614.98$662.48$662.48978,335
10/20/2026$626.64$637.15$613.13$622.43$622.43403,800
10/19/2026$619.33$625.69$616.13$619.66$619.66247,100
10/16/2026$630.29$632.33$610.05$618.47$618.47325,100

Analyst Price Targets

Based on 14 analysts covering MEDP · as of Oct 26, 2026

📉

Wall Street analysts forecast MEDP stock price to fall 4.8% over the next 12 months.

Consensus

Hold

3.07 / 5.00

Avg. Target

US$644.77

-4.8% Upside

Previously US$595.92 on Oct 12, 2026

Current Price

US$677.56

Last close

Analyst Breakdown (14 analysts)

Strong Buy 1
Buy 1
Hold 11
Strong Sell 1
Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on MEDP's historical volatility

HistoricalForecast68%95%
US$497.41US$643.71US$790.01US$936.31US$1082.61US$1228.91TodayJun 24Aug 27Oct 29Dec 11Jan 24Mar 8

30-Day Vol

32.4%

Annualized

90-Day Vol

36.1%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

US$810.03

Expected price

HorizonExpected68% Range (1σ)
30 trading daysUS$719.12US$643.06 – US$804.17
60 trading daysUS$763.22US$651.61 – US$893.94
90 trading daysUS$810.03US$667.44 – US$983.08

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Financials

Revenue (TTM)
$2.84B
EBITDA
$634.46M
Profit Margin
18.24%
ROE (TTM)
117.88%
EPS (Diluted)
18.01
Book Value
20.92

Classification

Sector
Health Care
Industry
Life Sciences Tools & Services
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Common Questions About MEDP.US

Market movers

Recent NASDAQ movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
PCLAPicoCELA Inc. American Depositary Shares$11.10+86.09%
GENVRGen Digital Inc. Contingent Value Rights$1.75+65.09%
NCPLNetcapital Inc$1.78+61.82%
INLFINLIF LIMITED Ordinary Shares$0.27+47.22%
XCHXCHG Limited American Depositary Share$3.46+41.80%
AMPGZAmplitech Group, Inc. Series B Right$0.05+40.80%
SGLYSingularity Future Technology Ltd$0.50+40.17%
JFINJiayin Group Inc$1.72+37.60%

MEDP.US news timeline

2 articles covering MEDP.US, most recent first

Latest

Medpace Raises 2026 EPS Guidance Range: What Investors Should Know

•Stocks